Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephrotic Syndrome | 21 | 2023 | 380 | 5.780 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 15 | 2024 | 333 | 3.820 |
Why?
|
| Kidney Glomerulus | 6 | 2021 | 568 | 1.420 |
Why?
|
| Genomics | 11 | 2023 | 5929 | 1.250 |
Why?
|
| Kidney Diseases | 7 | 2023 | 2098 | 1.060 |
Why?
|
| Urinary Tract | 5 | 2019 | 305 | 1.040 |
Why?
|
| Kidney | 13 | 2023 | 7066 | 0.890 |
Why?
|
| Alleles | 11 | 2021 | 6897 | 0.800 |
Why?
|
| Genome-Wide Association Study | 15 | 2023 | 12807 | 0.770 |
Why?
|
| Renal Insufficiency, Chronic | 6 | 2023 | 2310 | 0.700 |
Why?
|
| Multiple Endocrine Neoplasia Type 2a | 1 | 2019 | 40 | 0.660 |
Why?
|
| Nephrology | 2 | 2020 | 270 | 0.640 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2019 | 228 | 0.570 |
Why?
|
| Nephrosis, Lipoid | 4 | 2024 | 45 | 0.560 |
Why?
|
| Podocytes | 5 | 2023 | 391 | 0.560 |
Why?
|
| Genetic Testing | 5 | 2020 | 3595 | 0.530 |
Why?
|
| Access to Information | 1 | 2019 | 317 | 0.520 |
Why?
|
| Apolipoproteins | 2 | 2023 | 327 | 0.460 |
Why?
|
| Proteinuria | 5 | 2023 | 607 | 0.450 |
Why?
|
| Glomerulonephritis, Membranous | 4 | 2024 | 84 | 0.430 |
Why?
|
| Genetics, Population | 2 | 2015 | 943 | 0.430 |
Why?
|
| Kidney Tubules | 1 | 2015 | 453 | 0.420 |
Why?
|
| Genotype | 15 | 2023 | 13024 | 0.420 |
Why?
|
| Quantitative Trait Loci | 4 | 2022 | 2140 | 0.410 |
Why?
|
| Genetic Variation | 6 | 2021 | 6610 | 0.390 |
Why?
|
| Polymorphism, Single Nucleotide | 14 | 2023 | 16047 | 0.380 |
Why?
|
| Microfluidics | 1 | 2016 | 651 | 0.360 |
Why?
|
| Lipoproteins, HDL | 1 | 2015 | 674 | 0.360 |
Why?
|
| Premature Birth | 2 | 2023 | 1829 | 0.330 |
Why?
|
| Selection, Genetic | 1 | 2013 | 878 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2010 | 340 | 0.310 |
Why?
|
| Hirschsprung Disease | 1 | 2010 | 164 | 0.310 |
Why?
|
| Genetic Predisposition to Disease | 13 | 2023 | 18071 | 0.300 |
Why?
|
| Sequence Deletion | 2 | 2015 | 1495 | 0.280 |
Why?
|
| Haplotypes | 4 | 2023 | 2728 | 0.280 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 3655 | 0.280 |
Why?
|
| Software | 3 | 2020 | 4462 | 0.260 |
Why?
|
| Ubiquitins | 2 | 2018 | 365 | 0.240 |
Why?
|
| Child | 20 | 2024 | 80564 | 0.230 |
Why?
|
| DNA Copy Number Variations | 3 | 2019 | 2045 | 0.230 |
Why?
|
| Glomerulonephritis | 2 | 2018 | 332 | 0.220 |
Why?
|
| Glomerular Filtration Rate | 5 | 2023 | 2233 | 0.210 |
Why?
|
| Humans | 60 | 2024 | 765968 | 0.210 |
Why?
|
| Bayes Theorem | 2 | 2023 | 2354 | 0.200 |
Why?
|
| Hematuria | 1 | 2023 | 230 | 0.200 |
Why?
|
| Chromatin | 2 | 2023 | 2980 | 0.180 |
Why?
|
| Phenotype | 8 | 2018 | 16721 | 0.180 |
Why?
|
| Adenosine Deaminase | 1 | 2022 | 251 | 0.170 |
Why?
|
| Age of Onset | 2 | 2017 | 3344 | 0.160 |
Why?
|
| Kidney Failure, Chronic | 3 | 2022 | 2495 | 0.160 |
Why?
|
| Membrane Proteins | 6 | 2021 | 7851 | 0.160 |
Why?
|
| Angiogenic Proteins | 1 | 2019 | 101 | 0.160 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2022 | 792 | 0.160 |
Why?
|
| Urogenital Abnormalities | 2 | 2018 | 255 | 0.160 |
Why?
|
| Interferon Type I | 1 | 2022 | 567 | 0.150 |
Why?
|
| HLA-DQ Antigens | 1 | 2018 | 190 | 0.150 |
Why?
|
| Genetics, Medical | 1 | 2020 | 334 | 0.140 |
Why?
|
| Adolescent | 12 | 2024 | 88835 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 2900 | 0.140 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2017 | 41 | 0.140 |
Why?
|
| Diacylglycerol Kinase | 1 | 2017 | 47 | 0.140 |
Why?
|
| Steroids | 2 | 2020 | 933 | 0.130 |
Why?
|
| HLA-DR Antigens | 1 | 2018 | 608 | 0.130 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 376 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 5 | 2022 | 4772 | 0.130 |
Why?
|
| Young Adult | 8 | 2023 | 59889 | 0.130 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2015 | 17 | 0.130 |
Why?
|
| Chemokine CXCL11 | 1 | 2015 | 43 | 0.130 |
Why?
|
| Chromosome Deletion | 2 | 2018 | 1385 | 0.130 |
Why?
|
| Genetic Association Studies | 4 | 2019 | 2741 | 0.120 |
Why?
|
| Chemokine CXCL9 | 1 | 2015 | 137 | 0.120 |
Why?
|
| DiGeorge Syndrome | 1 | 2017 | 187 | 0.120 |
Why?
|
| Cohort Studies | 10 | 2024 | 41649 | 0.120 |
Why?
|
| Rare Diseases | 2 | 2024 | 635 | 0.120 |
Why?
|
| Pedigree | 3 | 2019 | 4526 | 0.120 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2018 | 434 | 0.120 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 334 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 938 | 0.120 |
Why?
|
| Child, Preschool | 7 | 2024 | 42500 | 0.120 |
Why?
|
| Case-Control Studies | 8 | 2020 | 22223 | 0.110 |
Why?
|
| RNA Splice Sites | 1 | 2015 | 212 | 0.110 |
Why?
|
| Adult | 16 | 2023 | 223044 | 0.110 |
Why?
|
| Fetal Development | 1 | 2019 | 777 | 0.110 |
Why?
|
| Risk Factors | 8 | 2023 | 74840 | 0.100 |
Why?
|
| Autoantibodies | 1 | 2021 | 2113 | 0.100 |
Why?
|
| Epidermal Growth Factor | 1 | 2015 | 698 | 0.100 |
Why?
|
| Female | 25 | 2024 | 396112 | 0.100 |
Why?
|
| Congenital Abnormalities | 1 | 2017 | 704 | 0.100 |
Why?
|
| Introns | 1 | 2015 | 966 | 0.100 |
Why?
|
| Reference Values | 2 | 2016 | 4908 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4260 | 0.100 |
Why?
|
| Mucins | 1 | 2015 | 567 | 0.100 |
Why?
|
| Biopsy | 5 | 2015 | 6763 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2019 | 2666 | 0.090 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2015 | 385 | 0.090 |
Why?
|
| Infant, Newborn | 5 | 2023 | 26346 | 0.090 |
Why?
|
| Genes, Recessive | 1 | 2013 | 624 | 0.090 |
Why?
|
| Male | 23 | 2024 | 363698 | 0.090 |
Why?
|
| Atrophy | 1 | 2015 | 1635 | 0.080 |
Why?
|
| Point Mutation | 1 | 2015 | 1590 | 0.080 |
Why?
|
| Ear | 1 | 2010 | 172 | 0.080 |
Why?
|
| Prognosis | 6 | 2023 | 29922 | 0.080 |
Why?
|
| Mutation | 4 | 2020 | 30198 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2019 | 2631 | 0.080 |
Why?
|
| Gene Frequency | 1 | 2016 | 3624 | 0.080 |
Why?
|
| Exons | 1 | 2015 | 2391 | 0.080 |
Why?
|
| Fibrosis | 1 | 2015 | 2070 | 0.070 |
Why?
|
| Mutation, Missense | 1 | 2016 | 2589 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 6069 | 0.070 |
Why?
|
| Databases, Genetic | 1 | 2013 | 1751 | 0.070 |
Why?
|
| Internet | 2 | 2016 | 3106 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 9525 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 20124 | 0.060 |
Why?
|
| Graft Rejection | 1 | 2019 | 4499 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 3596 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 15398 | 0.060 |
Why?
|
| Middle Aged | 9 | 2023 | 223009 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2022 | 12768 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 2975 | 0.060 |
Why?
|
| Risk | 1 | 2016 | 9591 | 0.060 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 4270 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2019 | 3458 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12976 | 0.050 |
Why?
|
| Neptune | 1 | 2023 | 2 | 0.050 |
Why?
|
| DNA Mutational Analysis | 3 | 2017 | 4108 | 0.050 |
Why?
|
| Alternative Splicing | 2 | 2021 | 1107 | 0.050 |
Why?
|
| Gene Expression | 1 | 2015 | 7584 | 0.050 |
Why?
|
| Heart Defects, Congenital | 1 | 2019 | 4697 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5783 | 0.050 |
Why?
|
| Zebrafish | 3 | 2019 | 3036 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3797 | 0.050 |
Why?
|
| Inosine | 1 | 2022 | 129 | 0.050 |
Why?
|
| RNA Editing | 1 | 2022 | 148 | 0.050 |
Why?
|
| RNA, Double-Stranded | 1 | 2022 | 292 | 0.050 |
Why?
|
| Hypertension | 1 | 2021 | 8626 | 0.050 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2020 | 12 | 0.040 |
Why?
|
| Insulin, Long-Acting | 1 | 2000 | 59 | 0.040 |
Why?
|
| Genome, Human | 1 | 2013 | 4448 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2022 | 515 | 0.040 |
Why?
|
| Receptors, Phospholipase A2 | 1 | 2020 | 31 | 0.040 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2020 | 103 | 0.040 |
Why?
|
| United States | 2 | 2017 | 72903 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2001 | 640 | 0.040 |
Why?
|
| Interferon Regulatory Factors | 1 | 2020 | 271 | 0.040 |
Why?
|
| Africa, Northern | 1 | 2018 | 85 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2023 | 871 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2019 | 8278 | 0.040 |
Why?
|
| Clathrin | 1 | 2019 | 259 | 0.040 |
Why?
|
| Adenosine | 1 | 2022 | 806 | 0.040 |
Why?
|
| Exocytosis | 1 | 2019 | 323 | 0.040 |
Why?
|
| Lithuania | 1 | 2017 | 13 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2017 | 54802 | 0.040 |
Why?
|
| Histocompatibility Testing | 1 | 2019 | 726 | 0.040 |
Why?
|
| Heredity | 1 | 2017 | 149 | 0.030 |
Why?
|
| Cell Movement | 2 | 2019 | 5194 | 0.030 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1997 | 141 | 0.030 |
Why?
|
| France | 1 | 2018 | 495 | 0.030 |
Why?
|
| Research Design | 1 | 2013 | 6209 | 0.030 |
Why?
|
| Spain | 1 | 2018 | 483 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 924 | 0.030 |
Why?
|
| Italy | 1 | 2018 | 854 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 1679 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2017 | 348 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2019 | 907 | 0.030 |
Why?
|
| Uncertainty | 1 | 2020 | 761 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 1044 | 0.030 |
Why?
|
| Probability | 1 | 2020 | 2475 | 0.030 |
Why?
|
| Base Composition | 1 | 2015 | 291 | 0.030 |
Why?
|
| Birth Weight | 1 | 2023 | 2121 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 2015 | 362 | 0.030 |
Why?
|
| Endocytosis | 1 | 2019 | 951 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2020 | 6255 | 0.030 |
Why?
|
| Genome | 1 | 2022 | 1753 | 0.030 |
Why?
|
| Lidocaine | 1 | 1997 | 550 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2022 | 3160 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 735 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 858 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2019 | 1339 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 2016 | 429 | 0.030 |
Why?
|
| Protein Transport | 1 | 2019 | 1939 | 0.030 |
Why?
|
| Chromosomes, Human, X | 1 | 2015 | 319 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 14751 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2018 | 1370 | 0.030 |
Why?
|
| Homozygote | 1 | 2017 | 1775 | 0.030 |
Why?
|
| Animals | 6 | 2022 | 168764 | 0.020 |
Why?
|
| Mice | 4 | 2022 | 81819 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2015 | 12240 | 0.020 |
Why?
|
| Models, Animal | 1 | 2017 | 2120 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 59489 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 523 | 0.020 |
Why?
|
| Heterozygote | 1 | 2017 | 2794 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2020 | 5379 | 0.020 |
Why?
|
| Remission Induction | 1 | 2015 | 2411 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2019 | 3634 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2019 | 2395 | 0.020 |
Why?
|
| North America | 1 | 2013 | 1285 | 0.020 |
Why?
|
| Systems Biology | 1 | 2013 | 481 | 0.020 |
Why?
|
| India | 1 | 2015 | 2334 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2021 | 8532 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 13400 | 0.020 |
Why?
|
| Time Factors | 2 | 2023 | 40065 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 4528 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2021 | 4424 | 0.020 |
Why?
|
| Regeneration | 1 | 2015 | 1517 | 0.020 |
Why?
|
| Prevalence | 1 | 2023 | 15842 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 1774 | 0.020 |
Why?
|
| Aged | 2 | 2015 | 171117 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 1509 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 15543 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10603 | 0.020 |
Why?
|
| Infant | 2 | 2017 | 36386 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 11888 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14448 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 9550 | 0.010 |
Why?
|
| Apoptosis | 1 | 2019 | 9514 | 0.010 |
Why?
|
| Liver | 1 | 1997 | 7562 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12509 | 0.010 |
Why?
|
| Proteins | 1 | 2015 | 5995 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 22332 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 18973 | 0.010 |
Why?
|
| Algorithms | 1 | 2020 | 14071 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2013 | 8733 | 0.010 |
Why?
|
| Incidence | 1 | 2017 | 21480 | 0.010 |
Why?
|
| Disease Progression | 1 | 2015 | 13632 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2015 | 11641 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 24282 | 0.010 |
Why?
|
| Pregnancy | 1 | 2019 | 30260 | 0.010 |
Why?
|
| Registries | 1 | 2013 | 8297 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18380 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 1997 | 525 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2019 | 23601 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2000 | 2108 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 2000 | 896 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2001 | 4618 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 4850 | 0.010 |
Why?
|
| Body Weight | 1 | 2000 | 4622 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2000 | 2592 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 17594 | 0.000 |
Why?
|
| Hypoglycemic Agents | 1 | 2000 | 3110 | 0.000 |
Why?
|
| Blood Glucose | 1 | 2000 | 6424 | 0.000 |
Why?
|
| Comorbidity | 1 | 2000 | 10563 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1997 | 9347 | 0.000 |
Why?
|
Concepts
(242)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(58)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_